The neuropsychiatry of multiple sclerosis: Focus on disorders of mood, affect and behaviour

References

• Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. Depression in multiple sclerosis: Relationship to working memory capacity. Neuropsychology 1999; 13: 546–556
   PubMed Web of Science ®Google Scholar
• Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Archives of Neurology 2004; 61: 525–528
   PubMed Web of Science ®Google Scholar
• Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000a; 11: 1153–1158
   PubMed Web of Science ®Google Scholar
• Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, et al. Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999; 53: 1151–1153
   PubMed Web of Science ®Google Scholar
• Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Multiple Sclerosis 2000b; 6: 181–185
   PubMed Web of Science ®Google Scholar
• Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Multiple Sclerosis 2008; 14: 1127–1130
   PubMed Web of Science ®Google Scholar
• Barak Y, Ur E, Achiron A. Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial. Journal of Neuropsychiatry and Clinical Neurosciences 1999; 11: 271–273
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. BDI-Fast screen for medical patients: Manual. The Psychological Corporation, San Antonio, TX 2000
   Google Scholar
• Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, et al. Depression and anxiety amongst multiple sclerosis patients. European Journal of Neurology 2008; 15: 239–245
   PubMed Web of Science ®Google Scholar
• Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multiple Sclerosis 2003; 9: 393–396
   PubMed Web of Science ®Google Scholar
• Buljevac D, Hop WC, Reedeker W, Janssens AC, van der Meche FG, van Doorn PA, et al. Self reported stressful life events and exacerbations in multiple sclerosis: Prospective study. British Medical Journal 2003; 327: 646
   PubMed Web of Science ®Google Scholar
• Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. American Journal of Psychiatry 2002; 159: 1862–1868
   PubMed Web of Science ®Google Scholar
• Cottrell SS, Wilson SAK. The affective symptomatology of disseminated sclerosis. Journal of Neurology and Psychopathology 1926; 7: 1–30
   PubMedGoogle Scholar
• Cummings JL. Frontal-subcortical circuits and human behavior. Archives of Neurology 1993; 50: 873–880
   PubMed Web of Science ®Google Scholar
• Cummings JL. Involuntary emotional expression disorder: Definition, diagnosis, and measurement scales. CNS Spectrum 2007; 12: 11–16
   Web of Science ®Google Scholar
• Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308–2314
   PubMed Web of Science ®Google Scholar
• D’Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study. Disability and Rehabilitation 2006; 28: 307–314
   PubMed Web of Science ®Google Scholar
• Dalos NP, Rabins PV, Brooks BR, O’Donnell P. Disease activity and emotional state in multiple sclerosis. Annals of Neurology 1983; 13: 573–577
   PubMed Web of Science ®Google Scholar
• Davison K, Bagley CR. Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature. British Journal of Psychiatry 1969; 4: 113–184
   Google Scholar
• Demaree HA, Gaudino E, DeLuca J. The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis. Cognitive Neuropsychiatry 2003; 8: 161–171
   PubMedGoogle Scholar
• Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. Journal of Neuropsychiatry and Clinical Neurosciences 1999; 11: 51–57
   PubMed Web of Science ®Google Scholar
• Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. Journal of the American Medical Association 1979; 241: 1011–1012
   PubMed Web of Science ®Google Scholar
• Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, et al. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: Association with cerebral inflammation. Archives of Neurology 1998; 55: 66–72
   PubMed Web of Science ®Google Scholar
• Feinstein A. Multiple sclerosis, disease modifying treatments and depression: A critical methodological review. Multiple Sclerosis 2000; 6: 343–348
   PubMedGoogle Scholar
• Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002; 59: 674–678
   PubMed Web of Science ®Google Scholar
• Feinstein A. Mood disorders in multiple sclerosis and the effects on cognition. Journal of Neurological Science 2006; 245: 63–66
   PubMed Web of Science ®Google Scholar
• Feinstein A, du Boulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. British Journal of Psychiatry 1992a; 161: 680–685
   PubMed Web of Science ®Google Scholar
• Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: A cognitive, psychiatric, and MRI follow up study. Journal of Neurology Neurosurgery and Psychiatry 1992b; 55: 869–876
   PubMed Web of Science ®Google Scholar
• Feinstein A, O’Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Multiple Sclerosis 1999a; 5: 323–326
   PubMed Web of Science ®Google Scholar
• Feinstein A, O’Connor P, Gray T, Feinstein K. Pathological laughing and crying in multiple sclerosis: A preliminary report suggesting a role for the prefrontal cortex. Multiple Sclerosis 1999b; 5: 69–73
   PubMed Web of Science ®Google Scholar
• Feinstein A, Feinstein K, Gray T, O’Connor P. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Archives of Neurology 1997; 54: 1116–1121
   PubMed Web of Science ®Google Scholar
• Feinstein A, Roy P, Lobaugh N, Feinstein K, O’Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62: 586–590
   PubMed Web of Science ®Google Scholar
• Ferentinos P, Kontaxakis V, Havaki-Kontaxaki B, Paparrigopoulos T, Dikeos D, Ktonas P, et al. Sleep disturbances in relation to fatigue in major depression. Journal of Psychosomatic Research 2009a; 66: 37–42
   PubMedGoogle Scholar
• Ferentinos P, Paparrigopoulos T, Rentzos M, Evdokimidis I. Duloxetine for pathological laughing and crying. International Journal of Neuropsychopharmacology 2009b; 12: 1429–1430
   PubMed Web of Science ®Google Scholar
• Ferentinos PP, Kontaxakis VP, Havaki-Kontaxaki BJ, Paplos KG, Soldatos CR. The measurement of fatigue in depression. Psychopathology 2007; 40: 133–134
   PubMedGoogle Scholar
• Figved N, Benedict R, Klevan G, Myhr KM, Nyland HI, Landro NI, et al. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Multiple Sclerosis 2008; 14: 1084–1090
   PubMedGoogle Scholar
• Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatrica Scandinavica 2005; 112: 463–468
   PubMed Web of Science ®Google Scholar
• Figved N, Myhr KM, Larsen JP, Aarsland D. Caregiver burden in multiple sclerosis: The impact of neuropsychiatric symptoms. Journal of Neurology Neurosurgery and Psychiatry 2007; 78: 1097–1102
   PubMed Web of Science ®Google Scholar
• Fishman I, Benedict RH, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. Journal of Neuropsychiatry and Clinical Neurosciences 2004; 16: 350–356
   PubMed Web of Science ®Google Scholar
• Flax JW, Gray J, Herbert J. Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry 1991; 148: 1603
   PubMed Web of Science ®Google Scholar
• Ford H, Trigwell P, Johnson M. The nature of fatigue in multiple sclerosis. Journal of Psychosomatic Research 1998; 45: 33–38
   PubMed Web of Science ®Google Scholar
• Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1984; 65: 135–138
   PubMed Web of Science ®Google Scholar
• Janssens AC, Buljevac D, van Doorn PA, van der Meche FG, Polman CH, Passchier J, et al. Prediction of anxiety and distress following diagnosis of multiple sclerosis: A two-year longitudinal study. Multiple Sclerosis 2006; 12: 794–801
   PubMed Web of Science ®Google Scholar
• Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurologica Scandinavica 2003; 108: 389–395
   PubMed Web of Science ®Google Scholar
• Joffe RT, Lippert GP, Gray TA. Personal and family history of affective illness in patients with multiple sclerosis. Journal of Affective Disorders 1987; 12: 63–65
   PubMed Web of Science ®Google Scholar
• Iriarte J, Subirá ML, Castro P. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Multiple Sclerosis 2000; 6: 124–130
   PubMed Web of Science ®Google Scholar
• Kim SW, Shin IS, Kim JM, Lim SY, Yang SJ, Yoon JS. Mirtazapine treatment for pathological laughing and crying after stroke. Clinical Neuropharmacology 2005; 28: 249–251
   PubMed Web of Science ®Google Scholar
• Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis 2007; 13: 67–72
   PubMed Web of Science ®Google Scholar
• Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Archives of Neurology 1988; 45: 435–437
   PubMed Web of Science ®Google Scholar
• Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, et al. Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956–1961
   PubMed Web of Science ®Google Scholar
• Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences 1997; 9: 283–292
   PubMedGoogle Scholar
• Larcombe NA, Wilson PH. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. British Journal of Psychiatry 1984; 145: 366–371
   PubMed Web of Science ®Google Scholar
• Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H, et al. Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica 2004; 110: 6–13
   PubMed Web of Science ®Google Scholar
• Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: The role of uncertainty, coping, and hope. Multiple Sclerosis 2001; 7: 411–416
   PubMed Web of Science ®Google Scholar
• Mattingly G, Baker K, Zorumski CF, Figiel GS. Multiple sclerosis and ECT: Possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients. Journal of Neuropsychiatry and Clinical Neurosciences 1992; 4: 145–151
   PubMed Web of Science ®Google Scholar
• McGuigan C, Hutchinson M. Unrecognized symptoms of depression in a community-based population with multiple sclerosis. Journal of Neurology 2006; 253: 219–223
   PubMed Web of Science ®Google Scholar
• Merkelbach S, Dillmann U, Kolmel C, Holz I, Muller M. Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis. Multiple Sclerosis 2001; 7: 320–326
   PubMed Web of Science ®Google Scholar
• Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, et al. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: An independent predictor of mental and physical status. Sleep Medicine 2009; 10: 26–34
   PubMed Web of Science ®Google Scholar
• Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. Journal of Clinical Endocrinology and Metabolism 1994; 79: 848–853
   PubMed Web of Science ®Google Scholar
• Minden SL, Orav J, Reich P. Depression in multiple sclerosis. General Hospital Psychiatry 1987; 9: 426–434
   PubMed Web of Science ®Google Scholar
• Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 1988; 38: 1631–1634
   PubMed Web of Science ®Google Scholar
• Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology 1990; 47: 98–103
   PubMed Web of Science ®Google Scholar
• Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001; 69: 942–949
   PubMed Web of Science ®Google Scholar
• Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Archives of Neurology 1997; 54: 531–533
   PubMed Web of Science ®Google Scholar
• Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA. A self report measure of affective lability. Journal of Neurology Neurosurgery and Psychiatry 1997; 63: 89–93
   PubMed Web of Science ®Google Scholar
• Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Multiple Sclerosis 2002; 8: 161–168
   PubMed Web of Science ®Google Scholar
• Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis. Paralyzed Veterans of America, Washington, DC 1998
   Google Scholar
• Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. Journal of Neuropsychiatry and Clinical Neurosciences 1998; 10: 453–455
   PubMed Web of Science ®Google Scholar
• Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004; 62: 2058–2064
   PubMed Web of Science ®Google Scholar
• Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Annals of Neurology 2006; 59: 780–787
   PubMed Web of Science ®Google Scholar
• Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: A link to the cerebellum. Brain 2001; 124: 1708–1719
   PubMed Web of Science ®Google Scholar
• Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM. Major depression in multiple sclerosis: A population-based perspective. Neurology 2003; 61: 1524–1527
   PubMed Web of Science ®Google Scholar
• Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis 2000; 6: 115–120
   PubMed Web of Science ®Google Scholar
• Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: Population-based evidence of an association. Neurology 2005; 65: 1123–1125
   PubMed Web of Science ®Google Scholar
• Pucak ML, Carroll KA, Kerr DA, Kaplin AI. Neuropsychiatric manifestations of depression in multiple sclerosis: Neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues in Clinical Neuroscience 2007; 9: 125–139
   PubMedGoogle Scholar
• Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997; 49: 1105–1110
   PubMed Web of Science ®Google Scholar
• Rabins PV. Euphoria in multiple sclerosis. Neurobehavioral aspects of multiple sclerosis, SM Rao. Oxford University Press, New York 1990; 180–185
   Google Scholar
• Ramasubbu R. Lamotrigine treatment for post-stroke pathological laughing and crying. Clinical Neuropharmacology 2003; 26: 233–235
   PubMed Web of Science ®Google Scholar
• Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. Journal of Neurology Neurosurgery and Psychiatry 2002; 72: 179–183
   PubMed Web of Science ®Google Scholar
• Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: Validation of a measurement scale and a double-blind treatment study. American Journal of Psychiatry 1993; 150: 286–293
   PubMed Web of Science ®Google Scholar
• Rosenberg JH, Shafor R. Fatigue in multiple sclerosis: A rational approach to evaluation and treatment. Current Neurology and Neuroscience Reports 2005; 5: 140–146
   PubMedGoogle Scholar
• Sabatini U, Pozzilli C, Pantano P, Koudriavtseva T, Padovani A, Millefiorini E, et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biological Psychiatry 1996; 39: 970–975
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193–1196
   PubMed Web of Science ®Google Scholar
• Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Archives of Neurology 1996; 53: 125–133
   PubMedGoogle Scholar
• Schiffer RB, Arnett P, Ben-Zacharia A, Benedict R, Bobholz J, Caruso L, et al. The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis 2005; 11: 328–337
   PubMedGoogle Scholar
• Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. New England Journal of Medicine 1985; 312: 1480–1482
   PubMed Web of Science ®Google Scholar
• Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. American Journal of Psychiatry 1990; 147: 1493–1497
   PubMed Web of Science ®Google Scholar
• Schiffer RB, Wineman N, Weitkamp MLR. Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry 1986; 143: 94–95
   PubMed Web of Science ®Google Scholar
• Schreurs KM, de Ridder DT, Bensing JM. Fatigue in multiple sclerosis: Reciprocal relationships with physical disabilities and depression. Journal of Psychosomatic Research 2002; 53: 775–781
   PubMed Web of Science ®Google Scholar
• Schubert DSP, Foliart RH. Increased depression in multiple sclerosis patients: A meta-analysis. Psychosomatics 1993; 34: 124–130
   PubMed Web of Science ®Google Scholar
• Sechi GP, Piras MR, Demurtas A, Tanca S, Rosati G. Dexamethasone-induced schizoaffective-like state in multiple sclerosis: Prophylaxis and treatment with carbamazepine. Clinical Neuropharmacology 1987; 10: 453–457
   PubMedGoogle Scholar
• Smith AG, Montealegre-Orjuela M, Douglas JE, Jenkins EA. Venlafaxine for pathological crying after stroke. Journal of Clinical Psychiatry 2003; 64: 731–732
   PubMed Web of Science ®Google Scholar
• Soldatos CR, Paparrigopoulos TJ. Sleep physiology and pathology: Pertinence to psychiatry. International Review of Psychiatry 2005; 17: 213–228
   PubMed Web of Science ®Google Scholar
• Stenager EN, Koch-Henriksen N, Stenager E. Risk factors for suicide in multiple sclerosis. Psychotherapy and Psychosomatics 1996; 65: 86–90
   PubMed Web of Science ®Google Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Trojan DA, Arnold D, Collet JP, Shapiro S, Bar-Or A, Robinson A, et al. Fatigue in multiple sclerosis: Association with disease-related, behavioural and psychosocial factors. Multiple Sclerosis 2007; 13: 985–995
   PubMed Web of Science ®Google Scholar
• Udaka F, Yamao S, Nagata H, Nakamura S, Kameyama M. Pathologic laughing and crying treated with levodopa. Archives of Neurology 1984; 41: 1095–1096
   PubMed Web of Science ®Google Scholar
• Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF, Galama JM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Archives of Neurology 1996; 53: 642–649
   PubMed Web of Science ®Google Scholar
• Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB. Pathological laughing and crying: Epidemiology, pathophysiology and treatment. CNS Drugs 2008; 22: 531–545
   PubMed Web of Science ®Google Scholar